Empower Clinic Services, LLC. (d/b/a Empower Pharmacy) vs. Eli Lilly & Co.

Explore the PTAB proceeding IPR2025-01024 filed by Empower Clinic Services, LLC. (d/b/a Empower Pharmacy) on 2025-05-22. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2025-01024

Filing Date

2025-05-22

Accorded Filing Date

2025-05-22

Institution Decision Date

2025-10-10

Last Modified Date

2026-03-23

Proceeding Type

IPR

Termination Date

2025-10-10

Trial Status

Discretionary Denial

Parties & Counsel

Petitioner

Empower Clinic Services, LLC. (d/b/a Empower Pharmacy)

Represented By

Mills, Jadet al

Patent Owner / Respondent

Eli Lilly & Co.

Represented By

Morin, Michaelet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 14987791

Respondent Patent Number 9474780

External Links

Espacenet

Google Patents

Respondent Inventor Bengt Krister Bokvist et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

48 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name ELI LILLY & COMPANY

Customer Number 25885

Address P.O. BOX 6288, PATENT DIVISION, INDIANAPOLIS, IN, 46206-6288, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
35241	James Leeds	317-276-1667
36711	Macharri Vorndran-Jones	317-276-1665
41264	Grant Reed	646-638-5003
43707	Gerald Keleher	317-276-3964
44646	Elizabeth Mcgraw	317-277-7443
45165	Robert Tucker	317-433-9829
45263	Arvie Anderson	317-277-7217
45609	Robert Sharp	317-651-1541
46903	Janet Martineau	206-715-7190
47145	Tina Tyson	317-277-3537
47504	Gregory Cox	317-277-2620
48613	Dan Wood	317-277-3366
48881	Gary Birch	317-276-0335
49013	Ann Chen	+86-21--2320-1399
50494	Bradley Crawford	2029628300
51417	Michael Asam	317-651-5646
51641	Ted Ebersole	317-433-2718
51820	Danica Hostettler	317-276-3711
52008	M Mcbride	414-277-5226
52373	Perry Woo	516-606-9772
56579	Nicole Woods	908-203-6835
57014	Yong Zhao	732-594-7338
57817	Congping Xie	317-433-2587
57909	Tonya Combs	317-651-1266
58241	Cedric D'Hue	176-541-25051
58392	Brian Cholewa	317-665-0387
59175	Bilyana Georgieva	317-800-8264
60723	Joseph Pletcher	317-277-4791
61806	Sanjay Jivraj	317-433-3495
61824	Marion Spillman	317-433-8735
62906	Jennifer Gregory	317-651-0116
63813	Robert Johnson	317-277-8747
64466	Jonathan Anderson	317-651-0640
65496	Matthew Lord	317-651-8072
66038	Thomas Weber	925-270-6764
66547	Duane Marks	317-521-2817
67097	Nicholas Kunz	602-790-8410
70773	Xiaoguang Gao	617-542-5070
71940	Parker Mccrary	317-719-7520
72408	Robert Shereda	734-489-8006
74850	Stefan Ochiana	202-970-3034
74973	Arthur Shum	617-526-6771
76145	Charles Rexer Jr.	212-301-0796
76639	Neelaabh Shankar	317-502-7117
77023	Shenshen Li	469-391-7451
78803	Gabriel Magallanes	317-276-2000
79494	Megan Fuller	317-586-1856
79584	Dipa Patel	908-704-2028

Proceeding Documents

183

Notice: refund approved NOTICE

2026-03-23 FILING PARTY: BOARD

Download

Petitioner's Request for Refund OTHER

2026-03-17 FILING PARTY: PETITIONER

Download

Order Denying Director Review of Institution Decision REHEARING

2026-01-12 FILING PARTY: BOARD

Download

Patent Owner's Authorized Response to Petitioner's Director Review Request OTHER

2025-11-20 FILING PARTY: PATENT OWNER

Download

3103

Ex. 3103 Counsel email for Authorized Response Exhibit

2025-11-13 FILING PARTY: BOARD

Download

Empower Clinic Services, LLC. (d/b/a Empower Pharmacy) vs. Eli Lilly & Co.

Proceeding Overview

Parties & Counsel

Petitioner

Empower Clinic Services, LLC. (d/b/a Empower Pharmacy)

Represented By

Patent Owner / Respondent

Eli Lilly & Co.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Notice: refund approved NOTICE

Petitioner's Request for Refund OTHER

Order Denying Director Review of Institution Decision REHEARING

Patent Owner's Authorized Response to Petitioner's Director Review Request OTHER

Ex. 3103 Counsel email for Authorized Response Exhibit

Request for Director Review - Institution Decision REQUEST

Director Discretionary Decision: Deny RESPONSE

Petitioner's Sur-reply Opposing Patent Owner's Discretionary Denial Request OTHER

Patent Owner's Reply in Support of Its Request for Discretionary Denial OTHER

Patent Owner's Updated Exhibit List NOTICE

Ex. 2088 Search Results from USP 9474780 File History Exhibit

Email Correspondence Exhibit

Ex. 2087 - Eli Lilly & Co - Q2 2025 Earnings Call Presentation Exhibit

EX1084 - Lilly. Exhibit

Ex. 2061 - Timofte 2013 Exhibit

Ex. 2054 - USP11357820 (B2) Exhibit

Ex. 2078 - Zepbound FDA Approval Exhibit

EX1085 - FDA clarifies policies. Exhibit

Ex. 2082 - Statista 2025 Exhibit

Ex. 2057 - Knudsen 2001 Exhibit

Ex. 2059 - Gattrell 2013 Exhibit

Ex. 2064 - USP Appl Publ 2016-0015788 A1 (Holscher) Exhibit

Petitioner's Opposition to Discretionary Denial. RESPONSE

Ex. 2075 - Empower Website Exhibit

EX1082 - Amin. Exhibit

EX1078 - Ferruggia. Exhibit

Ex. 2081 - Eli Lilly Co. 10-K (FY 2024) Exhibit

Ex. 2053 - Müller 2022 Exhibit

Ex. 2073 - Mounjaro Prescribing Information (May 2025) Exhibit

Ex. 2079 - PR Newswire (10.27.2023) Exhibit

Patent Owner's Preliminary Response POPR

EX1077 - Medicare Coverage of Anti-Obesity Medications. Exhibit

EX1076 - Tsipas Exhibit

Ex. 2084 - Sinha 2023 Exhibit

Ex. 2076 - Willard 2020 Exhibit

Ex. 2062 - Kueh 2014 Exhibit

Ex. 2074 - Zepbound Prescribing Information (Feb 2025) Exhibit

Ex. 2066 - Lorenz 2013 Exhibit

Ex. 2080 - Galien Foundation Website Exhibit

Ex. 2065 - Gao 2023 Exhibit

Ex. 2067 - Teng 2010 Exhibit

EX1080 - US12295987. Exhibit

EX1081 - US12343382. Exhibit

Ex. 2085 - Empower Website - About Us Exhibit

EX1079 - Allen. Exhibit

EX1086 - Wexler. Exhibit

Ex. 2063 - Knudsen 2000 Exhibit

Ex. 2077 - Mounjaro FDA Approval Exhibit

Ex. 2086 - Eli Lilly & Co, Press Release - Q2 2025 Earnings Call Exhibit

EX1083 - US8846628. Exhibit

Corrected Ex. 2029 - Chavda et al. (Molecules 2022) Exhibit

Email Correspondence Exhibit

Patent Owner's Updated Exhibit List NOTICE

Patent Owner's Updated Power of Attorney NOTICE

Patent Owner's Updated Mandatory Notices NOTICE

Ex. 2010 - Coskun et al. (Molecular Metabolism 2018) Exhibit

Ex. 2016 - Helfand (Fierce Pharma 10.8.2018) Exhibit

Ex. 2048 - Dowden & Munro (Nature Revs. Drug Discovery 2019) Exhibit

Ex. 2012 - Eli Lilly & Co Q3 2017 Earnings Call Transcript (10.24.2017) Exhibit

Ex. 2018 - Eli Lilly Press Release (2.17.2021) Exhibit

Ex. 2035 - Wang (Drug Design Dev. Therapy 2022) Exhibit

Patent Owner's Brief on Discretionary Denial RESPONSE

Ex. 2028 - Hosie (Business Insider 6.6.2022) Exhibit

Ex. 2031 - Drug Discovery Development (6.3.2021) Exhibit

Ex. 2043 - Eli Lilly Press Release (12.20.2024) Exhibit